Udo Geipel

519 total citations
21 papers, 387 citations indexed

About

Udo Geipel is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Udo Geipel has authored 21 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Udo Geipel's work include Clostridium difficile and Clostridium perfringens research (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Udo Geipel is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Udo Geipel collaborates with scholars based in Germany. Udo Geipel's co-authors include Klaus Aktories, Beate Schering, Martin Herrmann, M. Bärmann, Gursharan S. Chhatwal, Ingo Just, Walter H. Traub, Dieter Haas, Mathias Herrmann and Dierk Bauer and has published in prestigious journals such as Biochemical Journal, Infection and Immunity and European Journal of Biochemistry.

In The Last Decade

Udo Geipel

21 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udo Geipel Germany 10 148 141 114 90 50 21 387
Laura M. Palma Medina Netherlands 12 105 0.7× 130 0.9× 33 0.3× 170 1.9× 21 0.4× 20 426
Eyal Paz Israel 4 71 0.5× 56 0.4× 51 0.4× 127 1.4× 14 0.3× 7 431
Vivek Murthy United States 10 229 1.5× 56 0.4× 33 0.3× 275 3.1× 45 0.9× 17 523
Mayuresh M. Abhyankar United States 19 374 2.5× 191 1.4× 219 1.9× 277 3.1× 15 0.3× 37 805
Françoise Donnadieu France 8 84 0.6× 42 0.3× 28 0.2× 217 2.4× 80 1.6× 10 380
Noemi Cifani Italy 13 112 0.8× 106 0.8× 91 0.8× 178 2.0× 11 0.2× 21 602
Kenneth L. Pinkston United States 12 125 0.8× 40 0.3× 25 0.2× 151 1.7× 67 1.3× 14 431
David Skibinski United States 11 81 0.5× 128 0.9× 45 0.4× 123 1.4× 7 0.1× 15 384
June Irvine United Kingdom 8 135 0.9× 70 0.5× 29 0.3× 99 1.1× 14 0.3× 9 376
Pulkit Gupta India 12 167 1.1× 67 0.5× 44 0.4× 282 3.1× 34 0.7× 38 534

Countries citing papers authored by Udo Geipel

Since Specialization
Citations

This map shows the geographic impact of Udo Geipel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Geipel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Geipel more than expected).

Fields of papers citing papers by Udo Geipel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Geipel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Geipel. The network helps show where Udo Geipel may publish in the future.

Co-authorship network of co-authors of Udo Geipel

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Geipel. A scholar is included among the top collaborators of Udo Geipel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Geipel. Udo Geipel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anagnostakos, Konstantinos, et al.. (2021). Occurrence of Rare Pathogens at the Site of Periprosthetic Hip and Knee Joint Infections: A Retrospective, Single-Center Study. Antibiotics. 10(7). 882–882. 15 indexed citations
2.
Wilmes, Dunja, et al.. (2020). Disseminated coccidioidomycosis: Monitoring of serologic markers for treatment response. Medical Mycology Case Reports. 29. 25–28. 3 indexed citations
4.
Lemmen, Sebastian, et al.. (2011). Infektionskontrolle im OP: Präventions- und Isolierungsmaßnahmen bei multiresistenten Erregern. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 137(3). 284–292. 2 indexed citations
5.
Geipel, Udo, et al.. (2010). MRSA-Management - Die Kombination von Surveillance und Therapie. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 135(6). 487–490. 1 indexed citations
6.
Geipel, Udo. (2009). Pathogenic organisms in hip joint infections. International Journal of Medical Sciences. 6(5). 234–240. 58 indexed citations
7.
Federspil, P. & Udo Geipel. (2009). Methicillinresistente Staphylokokken (MRSA, MRSE) im Nasen-, Nasennebenhöhlenbereich und Sputum. HNO. 57(4). 395–407. 4 indexed citations
8.
Geipel, Udo & Mathias Herrmann. (2005). Methicillin-resistente Staphylococcus aureus. Der Anaesthesist. 54(2). 155–162. 3 indexed citations
9.
Geipel, Udo & Mathias Herrmann. (2005). [The infected implant: bacteriology].. PubMed. 108(11). 961–975; quiz 976. 17 indexed citations
10.
Geipel, Udo & Mathias Herrmann. (2005). Das infizierte Implantat. Der Orthopäde. 34(2). 119–119. 3 indexed citations
11.
Geipel, Udo & Martin Herrmann. (2004). Das infizierte Implantat. Der Orthopäde. 33(12). 1411–1428. 48 indexed citations
13.
Traub, Walter H., et al.. (1998). Antibiotic Susceptibility Testing (Agar Disk Diffusion and Agar Dilution) of Clinical Isolates of <i>Corynebacterium jeikeium</i>. Chemotherapy. 44(4). 230–237. 18 indexed citations
15.
Geipel, Udo, Ingo Just, & Klaus Aktories. (1996). ADP-ribosylation of an approximately 70-kilodalton protein of Klebsiella pneumoniae. Infection and Immunity. 64(5). 1720–1723. 4 indexed citations
16.
Just, Ingo, Udo Geipel, Albrecht Wegner, & Klaus Aktories. (1990). De‐ADP‐ribosylation actin by Clostridium perfringens iota‐toxin and Clostridium botulinum C2 toxin. European Journal of Biochemistry. 192(3). 723–727. 12 indexed citations
17.
Geipel, Udo, Ingo Just, & Klaus Aktories. (1990). Inhibition of cytochalasin D-stimulated G-actin ATPase by ADP-ribosylation with Clostridium perfringens iota toxin. Biochemical Journal. 266(2). 335–339. 23 indexed citations
18.
Aktories, Klaus, et al.. (1990). Characterization of the ADP-ribosylation of actin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin.. PubMed. 84(4). 262–6. 1 indexed citations
19.
Geipel, Udo, Ingo Just, Beate Schering, Dieter Haas, & Klaus Aktories. (1989). ADP‐ribosylation of actin causes increase in the rate of ATP exchange and inhibition of ATP hydrolysis. European Journal of Biochemistry. 179(1). 229–232. 44 indexed citations
20.
Schering, Beate, M. Bärmann, Gursharan S. Chhatwal, Udo Geipel, & Klaus Aktories. (1988). ADP‐ribosylation of skeletal muscle and non‐muscle actin by Clostridium perfringens iota toxin. European Journal of Biochemistry. 171(1-2). 225–229. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026